Search Results - "Gams, RA"

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer by Swain, S M, Whaley, F S, Gerber, M C, Weisberg, S, York, M, Spicer, D, Jones, S E, Wadler, S, Desai, A, Vogel, C, Speyer, J, Mittelman, A, Reddy, S, Pendergrass, K, Velez-Garcia, E, Ewer, M S, Bianchine, J R, Gams, R A

“…To determine the cardioprotective effect of dexrazoxane (DZR) used in a doxorubicin-based combination therapy in advanced breast cancer. Between November 1988…”
Get more information

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy by Swain, S M, Whaley, F S, Gerber, M C, Ewer, M S, Bianchine, J R, Gams, R A

“…To assess whether dexrazoxane (DZR) given after a cumulative doxorubicin dose of 300 mg/m2 confers cardioprotection in patients with advanced breast cancer…”
Get more information

Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer by Vogel, C L, Schoenfelder, J, Shemano, I, Hayes, D F, Gams, R A

“…Scintigraphic flare in association with response to therapy has been well described in the medical literature. During the course of a recent breast cancer…”
Get more information

Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer by Vogel, C L, Shemano, I, Schoenfelder, J, Gams, R A, Green, M R

“…To explore further the efficacy of high-dose toremifene in patients with advanced breast cancer who had failed to respond to tamoxifen or whose disease had…”
Get more information

Chemotherapy of Intermediate- and High-Grade Non-Hodgkin’s Lymphomas With an Intensive Epirubicin-Containing Regimen by Zuckerman, Kenneth S., Case, Delvyn C., Gams, Richard A., Prasthofer, Edgar F.

“…An intensive chemotherapy regimen (EVDAC), including high-dose epirubicin, vincristine, and dexamethasone followed by cyclophosphamide and high-dose…”
Get full text

Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with an intensive epirubicin-containing regimen by Zuckerman, KS, Case, DC Jr, Gams, RA, Prasthofer, EF

“…An intensive chemotherapy regimen (EVDAC), including high-dose epirubicin, vincristine, and dexamethasone followed by cyclophosphamide and high-dose…”
Get full text

A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma by WOOLLEY, P. V, SCHULTZ, C. J, RODRIGUEZ, G. I, GAMS, R. A, ROWE, K. W, DADEY, M. L, VON HOFF, D. D, MCPHILLIPS, J. J

“…We have conducted a study of ilmofosine (1-hexadecylthio; 2-methoxyethyl-rac-glycero-3-phosphocholine) in non-small cell bronchogenic carcinoma, using a…”
Get full text

A common progenitor for human myeloid and lymphoid cells by PRCHAL, J. T, THROCKMORTON, D. W, CARROLL, A. J, FUSON, E. W, GAMS, R. A, PRCHAL, J. F

Get full text

Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study by Greenberg, B R, Reynolds, R D, Charron, C B, Squillace, K M, Lessin, L S, Case, Jr, D C, Gams, R A

“…Idarubicin, a new anthracycline analogue, is available in an oral preparation, and responses have been observed using relatively aggressive therapy in patients…”
Get more information

Lymphoblastic lymphoma: a clinicopathologic study of 95 patients by Nathwani, B N, Diamond, L W, Winberg, C D, Kim, H, Bearman, R M, Glick, J H, Jones, S E, Gams, R A, Nissen, N I, Rappaport, H

“…A retrospective clinicopathologic study of lymphoblastic lymphoma was based on 95 patients from the files of the Repository Center for Lymphoma Clinical…”
Get more information

Phase II study of intravenous idarubicin in unfavorable non-hodgkin's lymphoma by CASE, D. C, GERBER, M. C, GAMS, R. A, CRAWFORD, J, VOTAW, M. L, HIGANO, C. S, PRUITT, B. T, GOULD, J

“…Idarubicin, a new analogue of daunorubicin, was administered i.v. at a dose of 15 mg/m2 to 31 previously treated patients with unfavorable non-Hodgkin's…”
Get full text

Antiestrogenic potency of toremifene and tamoxifen in postmenopausal women by Homesley, H D, Shemano, I, Gams, R A, Harry, D S, Hickox, P G, Rebar, R W, Bump, R C, Mullin, T J, Wentz, A C, O'Toole, R V

“…In this nonblinded, controlled multicenter trial, postmenopausal women were randomly assigned to receive graded doses of toremifene and tamoxifen or no…”
Get more information

Mitoxantrone in malignant lymphoma by Gams, R A, Steinberg, J, Posner, L

“…Two phase II trials of mitoxantrone in refractory malignant lymphoma have been conducted. In the first of these, mitoxantrone (5 mg/m2) was given weekly for 6…”
Get more information

Complications of chemotherapy in the treatment of Hodgkin's disease by Gams, R A

Get more information

Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial by Gams, R A, Rainey, M, Dandy, M, Bartolucci, A A, Silberman, H, Omura, G

“…A total of 296 evaluable patients with unfavorable categories of malignant lymphoma were randomly assigned treatment with cyclophosphamide, vincristine, and…”
Get more information

Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease by Bartolucci, A A, Liu, C, Durant, J R, Gams, R A

“…Of 209 Hodgkin's disease patients treated at least 6 months with a five-drug combination of induction chemotherapy and having a complete remission, four…”
Get more information

Uterine Adenocarcinoma Metastatic to the Skin Responsive to Megestrol Acetate by Spencer, David M., Bigler, Lane R., Wilkin, Jonathan K., Gams, Richard A.

“…background. Although endometrial carcinoma is the most common gynecological cancer, it only rarely metastasizes to the skin, with a reported prevalence of…”
Get full text

Dystonia with droperidol therapy by Arrowsmith, J, Gams, R A

Get more information

Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease. A Southeastern Cancer Study Group trial by Gams, R A, Omura, G A, Velez-Garcia, E, Kellermeyer, R, Raney, M, Bartolucci, A A

“…The Southeastern Cancer Study Group has explored the use of alternating sequential combination chemotherapy in advanced Hodgkin's disease. Two hundred twelve…”
Get more information

Mitoxantrone in malignant lymphoma by Gams, R A, Bryan, S, Dukart, G, Weiss, A, Case, D, Jones, S, Stein, R

“…Two phase II trials of mitoxantrone (Novantrone; dihydroxyanthracenedione) in refractory malignant lymphoma have been conducted. In the first of these,…”
Get full text